Novel 5-Phenylmorphans as Opioid Receptor Antagonists: Synthesis, Structure-Activity Relationship, Biological Evaluation and Computational Modeling
Molecules · 2026
DOI: 10.3390/molecules31193508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Zahra Hasanpour und 15 weiteren Autor:innen. Beteiligte Einrichtung: Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse …. Hauptthemen laut MEDLINE: Narcotic Antagonists, Receptors, Opioid, Morphinans. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, NIDA NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
The widespread emergence of ultra-potent synthetic opioids in illicit drug supplies and the limited effectiveness of naloxone in reversing certain synthetic opioid overdoses highlight the urgent need for potent high-affinity opioid antagonists. This study describes an improved synthetic approach and structure-activity relationship (SAR) study of N-substituted analogs of a potent and active MOR antagonist, 3-((1S,5R,9R)-9-methyl-2-phenethyl-2-azabicyclo[3.3.1]nonan-5-yl)phenol ((1S,5R,9R)-1). Pharmacological activity of the synthesized compounds at mu (MOR), delta (DOR), and kappa (KOR) receptors was assessed via a cAMP accumulation assay, and metabolic stability was determined in a microsomal stability assay. Selected compounds underwent additional evaluation in a competition binding assay at the opioid receptors. We identified a 3,5-dichloro analog, 9w, that demonstrated superior MOR potency relative to naloxone in the cAMP assay and increased metabolic stability by 3-fold in comparison to (1S,5R,9R)-1, warranting further evaluation. Notably, no measurable MOR activity was detected for an N-cyclopropylmethyl analog, 9d. Docking and binding free energy analyses identified key differences in receptor engagement that may underlie its inactivity relative to the potent antagonist (1S,5R,9R)-1. This study describes key structural features governing opioid receptor activity and metabolic stability in N-substituted C9-methyl 5-phenylmorphans and informs our future design of MOR antagonists with improved pharmacological profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National I…
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 S. Limestone Street, Lexington, KY 40536, USA.
- Drug Metabolism and Pharmacokinetics Core, National Center for Advancing Translational Sciences, National Institutes of Health, Department of Health and Human Services, 9808 Medical Center Drive, Rockville, MD 20850-337…
- Department of Pharmacology and Toxicology, Virginia Commonwealth University, 1112 East Clay Street, Richmond, VA 23298, USA.
- Department of Pathophysiology and Integrative Biomedical Sciences and the Dalton Cardiovascular Research Center, University of Missouri, 1500 Research Park Dr., Columbia, MO 65211, USA.
- EXSCALATE-Dompé Farmaceutici SpA, via Tommaso De Amicis 95, 80131 Napoli, Italy.
ORCID-Profile: Zahra Hasanpour, Dan Luo, Thomas E Prisinzano, Carmine Talarico, Davide Graziani, Andrea R Beccari, Kenner C Rice, Agnieszka Sulima
Förderung
- Intramural NIH HHS
- NIDA NIH HHS
- NCATS NIH HHS
- NIAAA NIH HHS
- American Heart Association
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
- National Institutes of Health
Zitieren
APA
Hasanpour, Z., Luo, D., Prisinzano, T. E., Shah, P., Selley, D. E., Gillespie, J. C., Grisanti, L. A., Talarico, C., Graziani, D., Xu, X., Beccari, A. R., Kil, K. E., Kim, S. W., Jacobson, A. E., Rice, K. C., & Sulima, A. (2026). Novel 5-Phenylmorphans as Opioid Receptor Antagonists: Synthesis, Structure-Activity Relationship, Biological Evaluation and Computational Modeling. Molecules. https://doi.org/10.3390/molecules31193508
Vancouver
Hasanpour Z, Luo D, Prisinzano TE, Shah P, Selley DE, Gillespie JC, et al. Novel 5-Phenylmorphans as Opioid Receptor Antagonists: Synthesis, Structure-Activity Relationship, Biological Evaluation and Computational Modeling. Molecules. 2026. doi:10.3390/molecules31193508
BibTeX
@article{Hasanpour2026,
author = {Hasanpour, Zahra and Luo, Dan and Prisinzano, Thomas E and Shah, Pranav and Selley, Dana E and Gillespie, James C and Grisanti, Laurel A and Talarico, Carmine and Graziani, Davide and Xu, Xin and Beccari, Andrea R and Kil, Kun-Eek and Kim, Sung Won and Jacobson, Arthur E and Rice, Kenner C and Sulima, Agnieszka},
title = {Novel 5-Phenylmorphans as Opioid Receptor Antagonists: Synthesis, Structure-Activity Relationship, Biological Evaluation and Computational Modeling},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31193508}
}
EUVIMED